Potentiated Vaccine 

for Global Immunization

Company motto

• Potentiates vaccine for global immunization
  
• No child left alone without vaccine 

Vision statement 

• Innovative technology for novel vaccine 
  
• Cold chain free nasal vaccine 
  
• Peptide vaccine without pathogen 
  
• Low cost T-Cell therapy for cancer and infectious disease

What NA Vaccine Institute has

• An adjuvant for potentiated vaccine 
  
• An adjuvant for both parenteral and mucosal vaccination
• An adjuvant with a potent cell mediated immunity for cancer vaccines 
• The cost effective production system for the adjuvant 
• Produces 100K dose of the adjuvant in less than a month

What NA Vaccine Institute does

Adjuvant related business; 

Licensing out of the vaccine adjuvant and/or contract research for the adjuvant development

• Development of adjuvant for more potentiated but safer vaccines
• Development for adjuvant for more effective parentreal and mucosal vaccine
• Development for adjuvant for oral or nasal vaccine

Vaccine development; 

Own internal programs and collaboration with others

• Nasal flu vaccine with a broad spectrum protection
• Nasal vaccine without a medical staff 
• Vaccine without cold chain 
• Peptide based vaccine
• Neoantigenic cancer vaccine 

Where NA Vaccine Institute is heading to

• Development of novel adjuvant and enhanced vaccine for global immunization with lower cost and risk.
  
• Vaccines with the breakthrough features of the broad spectrum specificity by intradermal, oral, or nasal delivery routes.
  
• Vaccines with reduce cost and improve efficacy without  cold chain 
  
• Peptide vaccines without pathogen 
• Setting up the industrial standard for the production of the novel adjuvant molecule, the industrial scale production, and QC guide line for each production steps.